Close

Immune Design (IMDZ), Merck (MRK) Enter Collaboration to Test Two Immune Design Immuno-oncology Agents

August 10, 2015 8:23 AM EDT Send to a Friend
Immune Design (NASDAQ: IMDZ) announced it has entered into clinical collaboration agreements through subsidiaries of Merck (NYSE: MRK), known as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login